연구동향 분석

Haloperidol and Other Antipsychotics Exposure before Endometrial Cancer Diagnosis: A Population-based Case-control Study

Wei-Ling Chen Srinivasan Nithiyanantham Yan-Chiao Mao Chih-Hsin Muo Chih-Pin Chuu Shih-Ping Liu Min-Wei Huang Kuan-Pin Su 2022년

논문상세정보
인용/피인용
' Haloperidol and Other Antipsychotics Exposure before Endometrial Cancer Diagnosis: A Population-based Case-control Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Endometrial neoplasms
  • Haloperidol.
  • antipsychotic agents
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
41 0

0.0%

' Haloperidol and Other Antipsychotics Exposure before Endometrial Cancer Diagnosis: A Population-based Case-control Study' 의 참고문헌

  • Use of antipsychotics and risk of breast cancer : a Danish nationwide case-control study
  • The use of atypical antipsychotics and the risk of breast cancer
    Azoulay L [2011]
  • The epidemiology of endometrial cancer in young women
  • The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer
  • T-cell dysregulation in patients with hyperprolactinemia : effect of bromocriptine treatment
    Vidaller A [1986]
  • Schizophrenia and cancer : an epidemiological study
    Goldacre MJ [2005]
  • Role of exogenous and endogenous hormones in endometrial cancer : review of the evidence and research perspectives
  • Risk factors among young women with endometrial cancer : a Danish case-control study
    Parslov M [2000]
  • Reproductive, menstrual, and medical risk factors for endometrial cancer : results from a case-control study
    Brinton LA [1992]
  • Regulation of NK activity by the administration of bromocriptine in haloperidol-treated mice
    Nozaki H [1996]
  • Reduced number of natural killer cells in patients with pathological hyperprolactinemia
    Gerli R [1986]
  • Protective effect of curcumin and its combination with piperine(bioavailability enhancer)against haloperidol-associated neurotoxicity : cellular and neurochemical evidence
    Bishnoi M [2011]
  • Off-label use of antipsychotic medications in the department of Veterans Affairs health care system
    Leslie DL [2009]
  • Obesity, inflammatory markers, and endometrial cancer risk : a prospective case-control study
    Dossus L [2010]
  • Obesity, endogenous hormones, and endometrial cancer risk : a synthetic review
    Kaaks R [2002]
  • Metoclopramide-induced hyperprolactinemia affects mouse endometrial morphology
    Rossi AG [2002]
  • Mechanisms underlying the protective potential of alpha-tocopherol(vitamin E)against haloperidol-associated neurotoxicity
    Post A [2002]
  • Inflammatory events in endometrial adenocarcinoma
    Wallace AE [2010]
  • Inflammation-induced cancer : crosstalk between tumours, immune cells and microorganisms
    Elinav E [2013]
  • Inflammation, stress, and diabetes
  • Inflammation and endometrial cancer : a hypothesis
    Modugno F [2005]
  • Induction of reactive oxygen species in neurons by haloperidol
    Sagara Y [1998]
  • Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells : suppression of NF-kappaB and neuroprotection by antioxidants
    Post A [1998]
  • Increasing off-label use of antipsychotic medications in the United States, 1995-2008
  • Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins
  • Incidence of cancer among persons with schizophrenia and their relatives
  • Hyperprolactinemia: an inductor of neoplastic changes in endometrium? A report of two cases
    Dexeus S [1998]
  • Hyperprolactinemia associated with psychotropics--a review
  • Hyperprolactinemia and autoimmune diseases
    Orbach H [2007]
  • Human uterine epithelial cell secretions regulate dendritic cell differentiation and responses to TLR ligands
    Ochiel DO [2010]
  • Haloperidol suppresses murine dendritic cell maturation and priming of the T helper 1-type immune response
    Matsumoto A [2015]
  • Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women
    Yavuz D [2003]
  • Elevated C-reactive protein levels in overweight and obese adults
    Visser M [1999]
  • Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
    이봉주 [2013]
  • Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment : role in orofacial dyskinesia
    Bishnoi M [2008]
  • Deprenyl suppresses the oxidant stress associated with increased dopamine turnover
    Cohen G [1989]
  • Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia
    Emamian ES [2004]
  • Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia : a multiple-treatments meta-analysis
    Leucht S [2013]
  • Cancer statistics, 2019
    Siegel RL [2019]
  • Cancer risk and PCOS
    Dumesic DA [2013]
  • Cancer risk among users of neuroleptic medication : a population-based cohort study
    Dalton SO [2006]
  • Can the immune system still be efficient in the elderly? An immunological and immunoendocrine therapeutic perspective
    Pfister G [2008]
  • Autoantibody profile in the sera of women with hyperprolactinemia
    Buskila D [1995]
  • Antipsychotic-induced hyperprolactinemia
    Bostwick JR [2009]
  • Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review
    Wieck A [2003]
  • Antiproliferative effects of antiestrogens and inhibitors of growth factor receptor signaling on endometrial cancer cells
    Block M [2010]
  • Activation of striatal inflammatory mediators and caspase-3 is central to haloperidol-induced orofacial dyskinesia
    Bishnoi M [2008]
  • A review of the association between antipsychotic use and hyperprolactinaemia
    Bushe C [2008]
  • A case-control study of endometrial cancer after antipsychotics exposure in premenopausal women
    Yamazawa K [2003]